Is XBiotech Inc halal to invest in?

According to Musaffa's Shariah screening methodology, XBiotech Inc (XBIT) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is XBiotech Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes XBiotech Inc using these criteria to determine its compliance status.

Can Muslims buy shares of XBiotech Inc?

Muslim investors may consider investing in XBiotech Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is XBiotech Inc classified as NOT HALAL?

Musaffa determines the Shariah status of XBiotech Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for XBiotech Inc updated?

The Shariah compliance status of XBiotech Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like XBiotech Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of XBiotech Inc?

You can check the latest Shariah compliance status of XBiotech Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

XBIT Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 16, 2026

Report Source: 2025 Annual Report

XBiotech Inc. Stock Analysis XBIT

United States Health Care Micro Cap Report: 2025 Annual

XBiotech, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutic antibodies. The company is headquartered in Austin, Texas and currently employs 88 full-time employees. The company went IPO on 2015-04-15. The firm's True Human monoclonal antibodies are derived from human donors that mount a natural human immune response. The firm is focused on therapies that block a potent substance, known as interleukin-1 alpha (IL-1a), that mediates a number of pathophysiological processes including tissue breakdown (i.e. synovium, cartilage, bone), paraneoplastic angiogenesis and tumor stroma remodeling, formation of blood clots, malaise, muscle wasting and general inflammation. The company has various candidate products, including Natrunix. The company has a clinical-stage therapeutic for methicillin resistant Staphylococcus aureus (MRSA), and several pre-clinical-stage therapeutics, including an oral delivery antibody therapeutic for colon infection by C. difficile.

Key Statistics of XBiotech Inc (XBIT)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$2.54$2.58

Today's Open

$2.56

Volume

14.27K

P/E Ratio (TTM)

52 Week Range

$2.09$3.61

Market Cap

80.48M

Avg. Volume

24.49K

Dividend Yield

Financial Metrics & Statements of XBiotech Inc (XBIT)

FAQ's for XBiotech Inc (XBIT)

According to Musaffa’s Shariah screening methodology, XBiotech Inc (XBIT) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.